J Breast Cancer.
2020 Oct;23(5):577-577. 10.4048/jbc.2020.23.e54.
Corrigendum: Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-KinaseProtein Kinase B-Mammalian Target of Rapamycin Signaling
- Affiliations
-
- 1Department of Nuclear medicine, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- 2Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University, Jinan, China
- 3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China
- 4Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- 5Department of Forensic Medicine, Medical School of Xi'an Jiaotong University, Xi'an, China
- KMID: 2511838
- DOI: http://doi.org/10.4048/jbc.2020.23.e54
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling
- Association of Chemokines and Chemokine Receptor Expression with Monocytic-Myeloid-Derived Suppressor Cells during Tumor Progression
- Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation
- Translational Regulation: A Novel Target for Breast Cancer Therapy
- Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs)
